Design, Synthesis, and Biological Evaluation of Theranostic Vitamin–Linker–Taxoid Conjugates


Novel tumor-targeting theranostic conjugates <b>1</b> and <b>2</b>, bearing either a fluorine-labeled prosthetic as a potential <sup>18</sup>F-PET radiotracer (<b>1</b>) or a fluorescence probe (<b>2</b>) for internalization studies in vitro, were designed and synthesized. We confirmed efficient internalization of <b>2</b> in biotin-receptor positive (BR+) cancer cells via receptor-mediated endocytosis (RME) based on flow cytometry and confocal fluorescence microscopy (CFM) analyses, which exhibited very high specificity to BR+ cancer cells. The potency and cancer-cell selectivity of <b>1</b> were evaluated against MX-1, L1210FR and ID8 cancer cells (BR+) as well as L1210 cells and WI38 normal human lung fibroblast cells (biotin-receptor negative: BR−). In particular, we designed and performed an assay in the presence of glutathione ethyl ester (GSH-OEt) wherein only <b>1</b> molecules internalized into cells via RME in the first 24 h period exert cytotoxic effect. The observed selectivity of <b>1</b> was remarkable, with 2 orders of magnitude difference in IC<sub>50</sub> values between BR+ cancer cells and WI38 cells, demonstrating a salient feature of this tumor-targeted drug delivery system

Similar works

Full text

oaioai:figshare.com:article/2186683Last time updated on 2/12/2018

This paper was published in FigShare.

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.